Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Ataxia
65%
Levetiracetam
64%
Friedreich's Ataxia
51%
Motor Dysfunction
41%
Placebo
38%
Essential Tremor
36%
Varenicline
36%
Spinocerebellar Degeneration
36%
Chorea
23%
Syndrome
22%
Levodopa
21%
Constipation
21%
Prevalence
20%
Solifenacin
18%
Overactive Bladder
18%
Levodopa-Induced Dyskinesia
18%
Huntington Chorea
18%
Tegaserod
13%
Immunoglobulin
13%
Hyperhomocysteinemia
11%
Disease Exacerbation
11%
Vatiquinone
10%
Mood Disorder
9%
Sodium Valproate
9%
Disease Duration
9%
Zonisamide
9%
Biological Marker
9%
Coronavirinae
9%
Cognitive Defect
9%
Snoring
9%
Prostate Cancer
9%
Breast Cancer
9%
Uterine Cervix Cancer
9%
Congenital Malformation
9%
Teratogenesis
9%
Dyskinesia
8%
Dystonia
8%
Lamictal
7%
Enuresis
7%
Propranolol
7%
Side Effect
6%
Folic Acid
6%
Botulinum Toxin A
6%
Pregabalin
6%
Weakness
6%
Neural Tube Defect
6%
Nocturia
5%
Entacapone
5%
Cerebellar Ataxia
5%
Medicine and Dentistry
Parkinson's Disease
92%
Essential Tremor
45%
Stereotypic Movement Disorder
28%
Placebo
26%
Deep Brain Stimulation
19%
Solifenacin
18%
Overactive Bladder
18%
Friedreich's Ataxia
18%
Constipation
16%
Chorea
16%
Sleep Time
14%
Body Mass Index
14%
Levodopa
13%
COVID-19
13%
Zonisamide
13%
Community-Dwelling Older Adults
13%
Psychological Trauma
13%
Tegaserod
13%
Levetiracetam
12%
Prevalence
12%
Cervical Cancer
10%
Side Effect
10%
Breast Cancer
10%
Topiramate
9%
Ataxia
9%
Symptom
9%
Hyperhomocysteinemia
9%
Military Health
9%
Cardiovascular System
9%
Varenicline
9%
Mammography
9%
Prostate Cancer
9%
Sodium Valproate
9%
Teratogenesis
9%
Epileptic Seizure
9%
Congenital Malformation
9%
Point Mutation
9%
Cross Sectional Study
9%
Behavioral Risk Factor Surveillance System
8%
Lamotrigine
7%
Enuresis
7%
Limb Tremor
6%
Gabapentin
6%
Propranolol
6%
Health Care Cost
6%
Offspring
6%
Supplementation
6%
Folic Acid
6%
Neural Tube Defect
6%
Accelerometry
5%
Nursing and Health Professions
Parkinson's Disease
54%
Friedreich's Ataxia
46%
Sleep Time
29%
Essential Tremor
18%
Overactive Bladder
18%
Solifenacin
18%
Logistic Regression Analysis
16%
Behavioral Risk Factor Surveillance System
16%
Ataxia
15%
Syndrome
14%
Medicare
13%
Congestive Heart Failure
13%
Gait Analysis System
12%
Rating Scale
11%
Independent Practice Association
10%
Prevalence
10%
Household
10%
Papanicolaou Test
10%
Disease Duration
9%
Berg Balance Scale
9%
Placebo
9%
Mammography
9%
Body Weight
9%
Heart Disease
9%
Racial Group
9%
Cigarette Filter
9%
Adolescent
9%
Validation Study
9%
Enuresis
7%
Motor Dysfunction
6%
Effect Size
6%
Mood Disorder
6%
Cognitive Defect
6%
Sleep Disorder
5%
Correlation Coefficient
5%
Stride Length
5%
Nocturia
5%
Pilot Study
5%
Urinary Dysfunction
5%
